The Food and Drug Administration (FDA) is reporting that in the United States alone, 9 women have died from a rare form of cancer caused by breast implants.
The extremely rare cancer, called anaplastic large cell lymphoma (ALCL) affects cells in the immune system and can be found around the breast implant. It can be found in the skin or lymph nodes, and is not a type of breast cancer.
There have been 359 cases of the cancer reported in the United States as of Frebruary1, 2017.
The exact number of cases “remains difficult to determine due to significant limitations in world-wide reporting and lack of global implant sales data,” it said. The United States is the leader in breasts implant surgeries, so it is safe to say the number of cancer cases might be lower in other countries.
“All of the information to date suggests that women with breast implants have a low but increased risk of developing ALCL compared to women who do not have breast implants,” the FDA reported.
In 2011, the FDA had first raised the possibility of a small but significant risk of developing the cancer after getting breast implants. It asked doctors to see if they noticed changes in their patients and for women to check for symptoms such as fluid buildup, hardening or a mass around their implants. Symptoms of the cancer also include swelling and redness around the breast implants.
Most of the cancer cases occurred in people who had textured surfaces on their implants, rather than smooth surfaces. Of the 231 reports to the FDA that contained information about the implant, 203 had textured surfaces and 28 had smooth surfaces.
So far, most cases of ALCL have been described as a slow-growing that is treatable when it’s detected early.
About 10 to 11 million women in the world have breast implants, according to the American Society of Plastic Surgeons and the Plastic Surgeon Foundation. Less than 10 patients are diagnosed a year with breast implant-associated ALCL and one study estimated an incidence of 1 in 300,000, according to the two groups.
People who are considering getting breast implants should do their research and discuss with their surgeon about the risks and benefits between textured- and smooth-surfaced implants, the FDA advised.
People who already have breast implants should monitor their implants any changes and get routine screenings such as mammograms or MRIs as recommended by their doctors, the agency suggested.